James Hardin is a molecular biologist by training
with a Ph.D. from Purdue University and postdoctoral training at Harvard
University. He spent 25 years as a faculty member at Baylor College of
Medicine - University of Arkansas for medical sciences and Saint Louis
University. He was COO/Executive Vice President of the John Wayne Cancer
Center where he oversaw a staff of 200. He was CEO of Mitos
Pharmaceutical and has reviewed and made funding decisions on over 50
biotechnology companies. He has testified before national and state
Dr. Hardin has also led and participated in numerous NCI
cancer center accreditation site visits and has an extensive research
and science background. He has held faculty appointments in the
Department of Cell Biology at Baylor College of Medicine and in the
Departments of Biochemistry, Medicine, and Pathology at the University
of Arkansas for Medical Sciences from 1976 to 1998.
Dr. Hardin has received several honors, written numerous manuscripts
and book chapters, and serves on external review panels for the National
Institutes of Health, National Science Foundation, United States
Department of Agriculture, and American Cancer Society.
He has also had extensive experience in biotechnology, serving as
chairman of the University of Arkansas for Medical Sciences (UAMS)
patent committee and as a founding director of the V.A. Biomedical and
Research Foundation. He also developed the UAMS patent policy,
scientific fraud policy, and conflict of interest policy.